Milk-Derived Cationic Fraction for Bovine Mastitis Treatment
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current treatments for bovine mastitis are ineffective due to antibiotic resistance and require lengthy withholding periods, leading to economic losses and contamination risks in dairy production.
Innovation Solution
A treatment composition comprising a cationic fraction extracted from milk, including lactoferrin, lactoperoxidase, and angiogenin, which provides a synergistic antimicrobial and immune-boosting effect, eliminating the need for antibiotics and withholding periods.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If antibiotics are used to treat bovine mastitis, then bacterial infection is suppressed, but antibiotic resistance develops and withholding periods are required
Solution Approach 1:
The invention changes the chemical parameters of the treatment by using milk-derived components (lactoferrin, lactoperoxidase, lysozyme) instead of synthetic antibiotics. These natural components have different mechanisms of action that do not select for resistance in the same way antibiotics do, thereby maintaining treatment effectiveness while avoiding the harmful effects of antibiotic resistance and contamination
Solution Approach 2:
The invention extracts and utilizes specific antimicrobial components from milk (lactoferrin, lactoperoxidase, lysozyme) to create a treatment composition. By taking out these natural defense components and applying them therapeutically, the invention provides an alternative to antibiotics that maintains efficacy without the associated problems of resistance and withholding periods
2Object-affected harmful factors
If teat seal formulations include antibiotics or chemicals, then anti-microbial activity is achieved, but withholding periods and farmer workload increase
Solution Approach 1:
The invention uses milk-derived components that are naturally occurring and biocompatible. These components provide self-limiting antimicrobial activity without requiring synthetic chemicals or extended withholding periods. The natural components work within the physiological framework of the animal, providing protection without the time losses associated with antibiotic withholding periods
Solution Approach 2:
The invention changes the composition parameters of teat seal formulations by replacing synthetic antibiotics and chemicals with milk-derived components. This substitution maintains the anti-microbial function while eliminating the need for withholding periods and reducing farmer workload, as the natural components do not require the same regulatory waiting periods
3Productivity
If milk production capacity is increased, then economic output improves, but resistance to mastitis decreases
Solution Approach 1:
The invention applies antimicrobial treatment during the dry period before the onset of lactation and potential mastitis infection. By administering the milk-derived components prophylactically during this vulnerable period, the invention protects the udder without interfering with subsequent milk production, thereby maintaining both productivity and health
Solution Approach 2:
The invention extracts and utilizes milk-derived antimicrobial components to treat the udder during the dry period. This approach leverages the natural defense system that is already present in milk, providing protection during the period when milk production ceases but infection risk increases, thus preserving the animal's ability to produce milk in the subsequent lactation period
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The cationic fraction effectively prevents and treats bovine mastitis by offering direct antimicrobial and immune-boosting actions, reducing the risk of antibiotic resistance and contamination, while being naturally safe and cost-effective.
Implementation Method 1
A treatment composition comprising a cationic fraction extracted from milk, including lactoferrin, lactoperoxidase, and angiogenin
Implementation Method 2
A treatment composition comprising a cationic fraction extracted from milk, including lactoferrin, lactoperoxidase, and angiogenin
Implementation Method 3
which provides a synergistic antimicrobial and immune-boosting effect
Data Source
AI summary
A treatment composition for treating or preventing bovine mastitis, the treatment composition characterized in that it includes at least two components which have an isoelectric point of or above substantially 6.8 and is extracted from milk, or a milk derived substance.